These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30362223)

  • 41. Epidemiologic and statistical methods for comparative effectiveness research.
    Hlatky MA; Winkelmayer WC; Setoguchi S
    Heart Fail Clin; 2013 Jan; 9(1):29-36. PubMed ID: 23168315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Propensity score methods for confounding control in nonexperimental research.
    Brookhart MA; Wyss R; Layton JB; Stürmer T
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):604-11. PubMed ID: 24021692
    [No Abstract]   [Full Text] [Related]  

  • 43. [Benefits of large healthcare databases for drug risk research].
    Garbe E; Pigeot I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Aug; 58(8):829-837. PubMed ID: 26092163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magic Mirror, On the Wall-Which Is the Right Study Design of Them All?-Part II.
    Vetter TR
    Anesth Analg; 2017 Jul; 125(1):328-332. PubMed ID: 28609341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug safety data mining with a tree-based scan statistic.
    Kulldorff M; Dashevsky I; Avery TR; Chan AK; Davis RL; Graham D; Platt R; Andrade SE; Boudreau D; Gunter MJ; Herrinton LJ; Pawloski PA; Raebel MA; Roblin D; Brown JS
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):517-23. PubMed ID: 23512870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do the observational studies using propensity score analysis agree with randomized controlled trials in the area of sepsis?
    Zhang Z; Ni H; Xu X
    J Crit Care; 2014 Oct; 29(5):886.e9-15. PubMed ID: 24996762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Risks to Patient Privacy from Publishing Data from Clinical Anesthesia Studies.
    O'Neill L; Dexter F; Zhang N
    Anesth Analg; 2016 Jun; 122(6):2017-27. PubMed ID: 27172145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are Randomized Controlled Trials the (G)old Standard? From Clinical Intelligence to Prescriptive Analytics.
    Van Poucke S; Thomeer M; Heath J; Vukicevic M
    J Med Internet Res; 2016 Jul; 18(7):e185. PubMed ID: 27383622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials.
    Federer C; Yoo M; Tan AC
    Assay Drug Dev Technol; 2016 Dec; 14(10):557-566. PubMed ID: 27631620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Standardisation of the FAERS database: a systematic approach to manually recoding drug name variants.
    Wong CK; Ho SS; Saini B; Hibbs DE; Fois RA
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):731-7. PubMed ID: 26017154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of fibrin sealant during non-emergency surgery: a systematic review of evidence of benefits and harms.
    Edwards SJ; Crawford F; van Velthoven MH; Berardi A; Osei-Assibey G; Bacelar M; Salih F; Wakefield V
    Health Technol Assess; 2016 Dec; 20(94):1-224. PubMed ID: 28051764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sample size calculations for blinding assessment.
    Landsman V; Fillery M; Vernon H; Bang H
    J Biopharm Stat; 2018; 28(5):857-869. PubMed ID: 29157126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Large-scale evidence generation and evaluation across a network of databases (LEGEND): assessing validity using hypertension as a case study.
    Schuemie MJ; Ryan PB; Pratt N; Chen R; You SC; Krumholz HM; Madigan D; Hripcsak G; Suchard MA
    J Am Med Inform Assoc; 2020 Aug; 27(8):1268-1277. PubMed ID: 32827027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statistical methods for the meta-analysis of cluster randomization trials.
    Donner A; Piaggio G; Villar J
    Stat Methods Med Res; 2001 Oct; 10(5):325-38. PubMed ID: 11697225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The architecture of clinical research (From the "Biostatistics and Epidemiology Lecture Series, Part 1").
    Stoller JK
    Cleve Clin J Med; 2017 Sep; 84(9 Suppl 2):e2-e9. PubMed ID: 28937357
    [No Abstract]   [Full Text] [Related]  

  • 56. Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications.
    Serghiou S; Patel CJ; Tan YY; Koay P; Ioannidis JP
    J Clin Epidemiol; 2016 Mar; 71():58-67. PubMed ID: 26415577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinguishing Between Efficacy and Real-World Effectiveness: The Case for Thinking Beyond Classic Randomized Controlled Trial Design.
    Sites BD; Masaracchia MM; Davis M
    Reg Anesth Pain Med; 2017; 42(2):131-132. PubMed ID: 28207640
    [No Abstract]   [Full Text] [Related]  

  • 58. Combining randomized and non-randomized evidence in network meta-analysis.
    Efthimiou O; Mavridis D; Debray TP; Samara M; Belger M; Siontis GC; Leucht S; Salanti G;
    Stat Med; 2017 Apr; 36(8):1210-1226. PubMed ID: 28083901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Issues in the meta-analysis of cluster randomized trials.
    Donner A; Klar N
    Stat Med; 2002 Oct; 21(19):2971-80. PubMed ID: 12325113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals.
    Gabler NB; Duan N; Raneses E; Suttner L; Ciarametaro M; Cooney E; Dubois RW; Halpern SD; Kravitz RL
    Trials; 2016 Jul; 17(1):320. PubMed ID: 27423688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.